Department of Neurology, Duke University School of Medicine, Durham, North Carolina.
Department of Ophthalmology, Duke University School of Medicine, Durham, North Carolina.
Clin Neurol Neurosurg. 2024 Nov;246:108587. doi: 10.1016/j.clineuro.2024.108587. Epub 2024 Oct 10.
Migraine is an established risk factor for cerebral ischemic stroke, with an especially robust association in patients with migraine with aura. However, it is not known if migraine is a risk factor for retinal stroke (central or branch retinal artery occlusion; CRAO or BRAO).
We performed a retrospective, observational, cohort study using population-based data from the State Inpatient Databases and State Emergency Department Databases from New York (2006-2015), California (2003-2011), and Florida (2006-2015) to determine the association between hospital-documented migraine and retinal stroke. The primary exposure was hospital-documented migraine (ascertained from admission or emergency department diagnosis codes). The primary endpoint was time to hospital-documented CRAO (ICD-9-CM code 362.31 in the primary diagnosis position) and secondary endpoints included time to BRAO and any retinal artery occlusion (RAO). Cause-specific hazard models were used to model the association between migraine and subsequent CRAO.
Of 39,835,024 patients included in the study, 1109,140 had migraine documented during our two year ascertainment window. Patients with migraine were younger (40.2±15.2 vs. 46.9±19.8, standardized difference (SD) 0.38), more likely to be female (81.4 % vs. 54.7 %, SD 0.6), and had a lower burden of atrial fibrillation (4.5 % vs. 6.9 %, SD 0.1), chronic kidney disease (1.9 % vs. 3.6 %, SD 0.2), and congestive cardiac failure (2.7 % vs. 5.1 %, SD 0.12). Migraine was not associated with CRAO in the primary diagnostic position (adjusted hazard rate (aHR) 1.15 (95 % CI: 0.79-1.67). However, it was associated with CRAO in any diagnostic position (aHR 1.39 (95 % CI: 1.08-1.78). As positive controls, we replicated previously established associations of migraine with cerebral ischemic stroke (aHR 1.35 (95 % CI: 1.32-1.38) and embolic ischemic stroke (aHR 1.15 (95 % CI: 1.08-1.22).
In a large, nationally-representative, claims-based study of patients from 3 regions in the United States (US), we did not find an adjusted association between migraine and a primary discharge diagnosis of CRAO. Our hypothesis-generating finding that migraine was associated with CRAO when using a broader definition sets the stage for future work leveraging both outpatient and pharmacy based claims to further explore this finding.
偏头痛是脑缺血性中风的既定危险因素,在有先兆偏头痛患者中尤其存在强烈关联。然而,偏头痛是否是视网膜中风(中央或分支视网膜动脉阻塞;CRAO 或 BRAO)的危险因素尚不清楚。
我们使用来自纽约州(2006-2015 年)、加利福尼亚州(2003-2011 年)和佛罗里达州(2006-2015 年)的基于人群的州住院数据和州急诊数据库进行了一项回顾性、观察性队列研究,以确定医院记录的偏头痛与视网膜中风之间的关联。主要暴露因素为医院记录的偏头痛(通过入院或急诊诊断代码确定)。主要终点是医院记录的 CRAO(ICD-9-CM 代码 362.31 在主要诊断位置)的时间,次要终点包括 BRAO 和任何视网膜动脉阻塞(RAO)的时间。特定原因的风险模型用于对偏头痛与随后的 CRAO 之间的关联进行建模。
在研究中纳入的 39835024 名患者中,有 1109140 名患者在我们的两年确定窗口期间有偏头痛记录。偏头痛患者更年轻(40.2±15.2 岁比 46.9±19.8 岁,标准化差异(SD)为 0.38),更可能是女性(81.4%比 54.7%,SD 为 0.6),房颤负担较低(4.5%比 6.9%,SD 为 0.1),慢性肾脏病(1.9%比 3.6%,SD 为 0.2)和充血性心力衰竭(2.7%比 5.1%,SD 为 0.12)。偏头痛在主要诊断位置与 CRAO 无关(调整后的危险比(aHR)为 1.15(95%CI:0.79-1.67)。然而,它与任何诊断位置的 CRAO 相关(aHR 为 1.39(95%CI:1.08-1.78))。作为阳性对照,我们复制了先前偏头痛与脑缺血性中风(aHR 1.35(95%CI:1.32-1.38)和栓塞性缺血性中风(aHR 1.15(95%CI:1.08-1.22)的关联。
在一项来自美国 3 个地区的基于人群的大型、全国代表性索赔研究中,我们没有发现偏头痛与 CRAO 的主要出院诊断之间存在调整后的关联。我们假设生成的发现,即偏头痛与更广泛的定义下的 CRAO 相关,为未来利用门诊和药房基于索赔的工作奠定了基础,以进一步探索这一发现。